Collectively, these data showed that depletion of p62 abrogated the tumor-initiating efficiency and growth of BCSC-derived tumor xenografts in vivo, supporting a critical role of p62 in the promotion of breast cancer stem-like properties. The gene discussed is SQSTM1; the disease is breast carcinoma.